siRNA, Anti-Human FASLG, LNA(CAT#: SIRGT04239WQ-LNA)

The product SIRGT04239WQ-LNA is a type of small interfering RNA (siRNA) that targets FASLG gene and regulates the expression of gene. The siRNA interferes with the expression of FASLG gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification Locked Nucleic Acid (LNA)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_000639.2; NM_001302746.1
Alternative Names ALPS1B; APT1LG1; APTL; CD178; CD95-L; CD95L; FASL; TNFSF6; TNLG1A
Related Diseases Autoimmune Lymphoproliferative Syndrome, Lung Cancer
Purification HPLC
Target Gene
Gene ID 356
Uniprot ID P48023

Related Products